Displaced midshaft fractures of the clavicle: non-operative treatment versus plate fixation (Sleutel-TRIAL). A multicentre randomised controlled trial by Stegeman, Sylvia A et al.
STUDY PROTOCOL Open Access
Displaced midshaft fractures of the clavicle:
non-operative treatment versus plate fixation
(Sleutel-TRIAL). A multicentre randomised
controlled trial
Sylvia A Stegeman
1*†, Mireille de Jong
1†, Cornelis FM Sier
1†, Pieta Krijnen
1†, Jan W Duijff
1†, Tom PH van Thiel
2,
Piet AR de Rijcke
3, Nicolaj MR Soesman
4, Tjebbe Hagenaars
5, Freek D Boekhoudt
6, Mark R de Vries
7,
Gert R Roukema
8, Andras FK Tanka
9, Jephta van den Bremer
10, Hub GWM van der Meulen
11,
Maarten WGA Bronkhorst
12, Bart A van Dijkman
13, Stephan WAM van Zutphen
14, Dagmar I Vos
15,
Niels WL Schep
16, Martin G Eversdijk
17, Ger DJ van Olden
18, Johan GH van den Brand
19, Robert Jan Hillen
20,
Jan Paul M Frölke
21† and Inger B Schipper
1†
Abstract
Background: The traditional view that the vast majority of midshaft clavicular fractures heal with good functional
outcomes following non-operative treatment may be no longer valid for all midshaft clavicular fractures. Recent
studies have presented a relatively high incidence of non-union and identified speciic limitations of the shoulder
function in subgroups of patients with these injuries.
Aim: A prospective, multicentre randomised controlled trial (RCT) will be conducted in 21 hospitals in the
Netherlands, comparing fracture consolidation and shoulder function after either non-operative treatment with a
sling or a plate fixation.
Methods/design: A total of 350 patients will be included, between 18 and 60 years of age, with a dislocated
midshaft clavicular fracture. The primary outcome is the incidence of non-union, which will be determined with
standardised X-rays (Antero-Posterior and 30 degrees caudocephalad view). Secondary outcome will be the
functional outcome, measured using the Constant Score. Strength of the shoulder muscles will be measured with
a handheld dynamometer (MicroFET2). Furthermore, the health-related Quality of Life score (ShortForm-36) and the
Disabilities of Arm, Shoulder and Hand (DASH) Outcome Measure will be monitored as subjective parameters. Data
on complications, bone union, cosmetic aspects and use of painkillers will be collected with follow-up
questionnaires. The follow-up time will be two years. All patients will be monitored at regular intervals over the
subsequent twelve months (two and six weeks, three months and one year). After two years an interview by
telephone and a written survey will be performed to evaluate the two-year functional and mechanical outcomes.
All data will be analysed on an intention-to-treat basis, using univariate and multivariate analyses.
Discussion: This trial will provide level-1 evidence for the comparison of consolidation and functional outcome
between two standardised treatment options for dislocated midshaft clavicular fractures. The gathered data may
support the development of a clinical guideline for treatment of clavicular fractures.
Trial registration: Netherlands National Trial Register NTR2399
* Correspondence: S.A.Stegeman@lumc.nl
† Contributed equally
1Department of Surgery-Traumatology, Leiden University Medical Centre, P.O.
box 9600, 2300 RC Leiden, the Netherlands
Full list of author information is available at the end of the article
Stegeman et al. BMC Musculoskeletal Disorders 2011, 12:196
http://www.biomedcentral.com/1471-2474/12/196
© 2011 Stegeman et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Background
Epidemiology
Fractures of the clavicle account for 2.6 to 4 percent of all
adult fractures and 35 percent of all injuries to the
shoulder girdle [1,2]. The annual incidence of clavicular
fractures is estimated between 29 and 64 per 100,000.
Fractures of the middle third (midshaft) account for 69 to
82 percent of all clavicular fractures, whereas distal frac-
tures represent 21 to 28 percent. Medial-end injuries are
less common, approximately 2 to 3 percent of all clavicular
fractures [2,3]. The average age of patients sustaining a
midshaft clavicular fracture is 33 years, 70 percent of the
patients is male [4]. A fall or a direct blow to the shoulder,
giving an axial compressive force on the clavicle, is the
most common trauma mechanism of injury for any clavi-
cular fracture [5-7].
Current treatment concepts
Midshaft fractures have traditionally been treated non-
operatively, even when substantially displaced [8]. The
non-operative treatment strategy was based on early
reports suggesting that clavicular non-unions are very
r a r e .C l a v i c u l a rm a l - u n i o n ,i fp r e s e n t ,w a sr e p o r t e da s
being of radiographic interest only, without clinical impor-
tance [9]. Moreover, surgical treatment of acute midshaft
fractures was not favoured due to relatively frequent and
serious complications such as infection, non-union, pin
migration, broken plates, and necessity of removal of hard-
ware [2]. However, the prevalence of non-union or mal-
union in dislocated midshaft clavicular fractures after
conservative treatment is higher than previously presumed
and fixation methods have evolved. Of all midshaft clavi-
cular fractures, about two-thirds end up having some
degree of mal-union [5]. Recent studies reported a non-
union rate up to 15 percent and more [10,11,4] and a
potential 20 to 25 percent decrease in shoulder function
and arm strength [4,12,13,11,14-17].
The currently described indications for surgical treat-
ment are open fractures, neurovascular involvement, skin
compromise and wide separation of bone fragments with
soft tissue interposition. Initial clavicular shortening
exceeding 20 mm is upcoming as an indication for opera-
tive treatment, because shortening caused by dislocation
has been associated with potential shoulder dysfunction
[18,12]. An associated floating shoulder, or a scapular
neck fracture, are relative indications for operative treat-
ment of the clavicular fracture. Non-union and mal-union
are mentioned as a delayed indication for operative treat-
ment. If an operation is considered for displaced midshaft
clavicular fractures, the preferred method of fixation is
reduction and internal fixation by means of wires, pins, or
plates with screws.
Valid and scientific evidence showing primary operative
intervention to be superior compared to closed treatment
for dislocated fractures, still lacks [19,20]. Surgery is
accepted more and more as primary treatment for dislo-
cated midshaft clavicular fractures, mainly because the
results of non-operative treatment are interpreted as
inferior to operative treatment [9,15,21,22]. Several stu-
dies have examined the safety and efficacy of primary
open reduction and internal fixation (ORIF) for comple-
tely displaced midshaft clavicular fractures and have
noted a high union rate with a low complication rate
[23,24,11,9]. However, all these studies were retrospective
and only one recent study prospectively compared lock-
ing plate fixation with non-operative treatment [9]. In
this multicentre, prospective randomised trial 132
patients with a displaced midshaft clavicular fracture
were allocated to either operative treatment with plate
fixation (n = 67) or non-operative treatment (n = 65).
The investigators concluded that operative treatment
results in improved functional outcome and a lower rate
of mal-union and non-union compared with non-opera-
tive treatment after one year of follow-up [9]. One of the
important limitations of this prospective randomised trial
was a selective loss to follow-up, which occurred predo-
minantly in the non-operatively treated group. This may
have obscured the true difference in the outcome para-
meters between the study groups.
A cost-effectiveness analysis [4] has been performed in
this multicentre, prospective randomised trial [9], showing
that the cost-effectiveness of ORIF of displaced midshaft
clavicular fractures is dependent on the duration and mag-
nitude of functional benefit after ORIF, the disutility
before union and increased time to union associated with
non-operative treatment, and the actual cost of treatment.
Rationale for the trial
A multicentre randomised clinical trial with sufficient
power is needed to provide scientific support for a pre-
ferred treatment strategy for dislocated midshaft frac-
tures of the clavicle. The aim of this trial is to compare
the results of plate fixation with non-operative manage-
ment of dislocated midshaft fractures of the clavicle with
respect to the incidence of non-union, functional out-




The Sleutel-TRIAL is designed as a multicentre rando-
mised controlled trial. In total twenty-one academic and
non-academic centres in the Netherlands will participate.
The study started 15 June, 2010. The trial has been devel-
oped to meet the Declaration of Helsinki (59
th World
Medical Association General Assembly, Seoul, October
2008) and in accordance with the Medical Research
Involving Human Subjects Act [25]. It will follow the
Stegeman et al. BMC Musculoskeletal Disorders 2011, 12:196
http://www.biomedcentral.com/1471-2474/12/196
Page 2 of 7CONSORT (CONsolidation of Standards of Reporting
Trials) guidelines [26-28].
Recruitment, consent and randomisation
All eligible persons presenting at the Emergency Depart-
ment (ED) or at the outpatient clinic with a new, dislo-
cated midshaft clavicular fracture are informed about this
trial. They receive information and a consent form from
the attending physician, the physician assistant or the
clinical investigator. After written informed consent has
been obtained, the patient is randomised for either opera-
tive therapy with a plate fixation or for non-operative ther-
apy. Minimisation randomisation is accomplished via the
trial website using TenALEA (Trans European Network
for Clinical Trials Services), an online registration and ran-
domisation program. All patients are randomly allocated
to one of the two treatment arms in a 1:1 ratio in each
participating hospital. For each subsequent participant
the allocation depends on the included participants to
minimise the imbalance [29].
Study population
All patients with a dislocated midshaft clavicular fracture
have to meet the following inclusion criteria before
enrolment:
1. Fully displaced midshaft fracture (no fracture side con-
tact of distal and proximal fragments) according to Robin-
son classification 2B1 and2 B 2( s e eF i g u r e1 ) .T h e
classification of the fracture will be confirmed on an ante-
rior-posterior X-ray with a 30 degree caudocephalad view;
2. Age between 18 and 60 years;
3. No medical contra-indications to general anaesthesia;
4. Signed informed consent by the patient or a legal
representative;
If one of the following exclusion criteria applies, the
patient is not eligible for the study:
1. Fracture in the proximal or distal third of the
clavicle;
2. Pathologic fracture (bony abnormalities at the side
of the fracture) or an open fracture;
3. Neurovascular injury of the shoulder region with
objective neurological findings on physical examination;
4. Associated head injury (Glasgow Coma Scale < 12);
5. A significant ipsilateral upper extremity fracture,
that would delay the functional recovery of the arm;
6. A midshaft clavicular fracture more than 14 days
old at first hospital visit;
7. Inability to comply with follow-up;
8. Prior surgery to the shoulder or pre-existing
shoulder complaints with subsequent loss of function;
Interventions
For patients assigned to operative treatment, the proce-
dure of applying the plate is performed according to
standard procedures, including the position of the
patient (beach chair position) and anaesthesia (i.e., gen-
eral anaesthesia or interscalene nerve block or a combi-
nation of both). All patients admitted to the hospital for
operative intervention receive antibiotic prophylactics
(single dose) pre-operatively and after operation throm-
boprophylaxis is applied during the hospital stay (e.g.,
unfractionated heparin, Low Molecular Weight Heparin
(LMWH), or equivalent). All operations are performed
by skilled trauma surgeons, i.e. those who have per-
formed more than five operations with a plate fixation,
or by surgical residents under supervision of a skilled
trauma surgeon. No restrictions are specified regarding
the brand of plate fixation that will be used. Patients
Figure 1 Robinson Classification type 2 fractures. Figure reprinted with permission of C.M. Robinson [39]. Right side of the figure shows type
2B1 and type 2B2 fractures.
Stegeman et al. BMC Musculoskeletal Disorders 2011, 12:196
http://www.biomedcentral.com/1471-2474/12/196
Page 3 of 7assigned to conservative therapy wear a sling for the
first two weeks.
All patients, in both treatment arms, are advised to
mobilise the shoulder functionally without weight bear-
ing during the first six weeks. The exercise protocol con-
sists of pendulum exercises up to functional movements
without weight bearing in the first six weeks after trauma
or operation. In the first two weeks pendulum exercises
are started and more active exercise is initiated between
two and four weeks postoperatively or after trauma. After
six weeks, initial strengthening is started.
Outcome measures
The primary outcome is the incidence of non-union. This
is determined objectively on X-rays by an independent
radiologist and two surgeons, and subjectively by evalua-
tion of the clavicular and the arm function. The function
of the arm is measured with the Constant Score. The
Constant score consists of four variables, reflecting both
function and pain of the shoulder joint [30,31]. The sub-
jective variables in the Constant Score are pain, activities
of daily living and arm positioning. The objective vari-
ables are range of motion (ROM) without pain and
strength [32]. The arm strength is measured with the
MicroFET2 (Micro Force, Evaluating and Testing 2, Hog-
gan Health Industries Inc, West Jordan, UT, USA), a
hand-held dynamometer. This device measures the force
ap a t i e n tc a np r o d u c ea g a i n s tt h ef o r c eo ft h ee x a m i n e r
in Newton (N). All arm movements (i.e., retroflexion,
anteflexion, abduction, adduction, endorotation and
exorotation) are evaluated six weeks after initial trauma
or operation in comparison with the contralateral side
and thereafter at each follow-up moment. For all mea-
surements the Make Test is used. The Make Test is char-
acterised by the examiner holding the dynamometer
stationary while the subject exerts a maximal force
against the dynamometer and the examiner [33]. The
results produced with the hand-held dynamometer have
been shown to be reproducible, especially when mea-
sured by one single examiner at each hospital (intra-rater
reliability) [33]. The inter- and intra-rater reliability of
hand-held dynamometry varied in the range from good
to high [34,35].
Secondary outcomes are clinical function measured with
the DASH Outcome Measure, pain scores, cosmetic
aspects, quality of life and complications of the allocated
treatment. The Disabilities of Arm, Shoulder and Hand
(DASH) Outcome Measure is a validated 30-item, self-
report questionnaire designed to describe the disability
experienced by people with upper-limb disorders and to
monitor changes in symptoms and function over time.
The DASH Outcome Measure consists of two compo-
nents: the disability/symptom section (30 items) and the
optional high performance Sport/Music module (4 items).
The questions involve the degree of difficulty in perform-
ing a variety of physical activities because of problems
with the arm, shoulder, or hand. The severity of pain,
activity-related pain, tingling, weakness and stiffness is
investigated, as well as the effect of upper limb problems
on social activities, work, sleep, and self-image [36,32,37].
The questionnaire is filled out at each follow-up moment.
Cosmetic aspects are included in the follow-up ques-
tionnaires. These questions are subjective and involve
satisfaction with the appearance of the shoulder with and
without surgery. The Health Related Quality of Life (HR-
QOL) will be evaluated using the Short Form-36 (SF-36).
The SF-36 is a validated survey on general health with 36
questions, representing eight health domains that are com-
bined into a physical and a mental component scale [38].
The Physical Component Scale (PCS) contains the health
domains physical functioning, role limitations due to phy-
sical health, bodily pain and general health perceptions.
The Mental Component Scale (MCS) contains the health
domains vitality, energy, fatigue, social functioning, role
limitations due to emotional problems and general mental
health. Scores ranging from 0 to 100 points are derived for
each domain, with lower scores indicating poorer function.
These scores will be converted in a norm-based score and
compared with the norm values for the general population
of the United States (1998), in which each scale was scored
to have the same standardized average (50 points) and the
same standard deviation (10 points) [32].
Follow-up of patients
After inclusion, all patients will be followed for two years
in total. Patients will visit the outpatient clinic after two
weeks, six weeks, three months and one year. After two
years an interview by telephone and written survey will be
conducted to evaluate two-year functional and mechanical
outcome. In the operative group follow-up starts on the
day of surgery. For the non-operative group this is the day
of inclusion (see Table 1).
At each hospital visit various intrinsic (patient-related)
and injury-related variables are collected. As part of
standard care, X-rays are taken at admission and each
follow-up moment. The X-rays are performed in anterior-
posterior view and 30° caudocephalad view. After two
weeks an X-ray of the contralateral shoulder is taken for
comparison with the affected shoulder. The DASH out-
come measure and SF-36 are filled out by the patient after
two weeks, six weeks, three months and one year. The
Constant score of both shoulders is determined after six
weeks. The Constant score of the affected shoulder is also
determined after three months and one year. The func-
tional tests are performed by a single-blinded researcher
or other single-blinded qualified personnel. During these
tests, the patients have a sticker on the affected shoulder
and they are not allowed to tell the examiner which
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the researcher collects medical information according to
the follow-up list (i.e., complications/adverse events, sec-
ondary interventions). Serious adverse events will be
reported directly.
Sample size calculation
Based on a non-union difference of 15 percent in a pre-
vious study [9], the sample size of 175 patients per treat-
ment group was calculated with a power (1-b)o f8 0
percent and a type I error (a) of 5 percent, allowing for 12
percent drop-out. In total 350 patients will be included.
Statistical analysis
The research data will be reported following the CONsoli-
dated Standards of Reporting Trial (CONSORT) [26-28].
Complication rates and recovery of function of the
shoulder will be compared between the two intervention
groups using the Chi-squared test. All other endpoints will
be compared using co-variate analysis and student’sT - t e s t
or Mann-Whitney U-test for, respectively, parametric or
non-parametric data. Multivariate linear regression analy-
sis will be performed to model the relation between binary
outcome variables and treatment, adjusted for covariates.
Data will be presented as mean ± SD (Standard Deviation)
for parametric data or medians and percentiles (non-para-
metric data). P-values lower than 0.05 will be considered
statistically significant. The data will be analysed using
S P S Sv e r s i o n1 7o rh i g h e r( S t atistical Package for the
Social Sciences Inc, Chicago IL, USA).
Ethical considerations
The study will be carried out in compliance with the
Declaration of Helsinki on ethical principles for medical
research involving human subjects [25]. The Medical Ethics
Committee Leiden University Medical Centre (LUMC) acts
as central ethics committee for this trial (reference number
P10.033 and P10.169; NL31044.058.10 and NL3392
5.058.10). Approval has also been obtained from the local
Medical Ethics Committees of all participating centres. The
Medical Ethics Committee LUMC has given dispensation
from the statutory obligation to provide insurance for sub-
jects participating in medical research (Medical Research
(Human Subjects) Compulsory Insurance Decree of 23
June 2003), because the study concerns two standard treat-
ments and does not introduce extra risks.
Discussion
The best treatment strategy for dislocated midshaft clavi-
cular fractures remains a topic of debate. Currently, the
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2
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Case Record Form + Randomisation form ￿













SF-36 score (Quality of Life) ￿￿￿ ￿
Constant score (+MicroFET2) ￿￿ ￿
Telephone interview and written survey ￿
￿ 1: obtaining Informed Consent (verbally) for randomisation and planning of clinic visit.
￿ 2: obtaining definitive written Informed Consent.
￿ 3: X-rays: AP-view and 30 degrees cephalad view.
￿ 4: Panorama view.
￿ 5: Forms for the corresponding visit.
†: only for participants allocated to operative treatment.
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Page 5 of 7decision for non-operative or operative treatment of dis-
located midshaft clavicular fractures is predominantly
based upon the personal preferences of the treating sur-
geon. In a similar way, when operative treatment is
favoured, the type of fixation, intramedullary or (locking)
plate fixation, is at the discretion of the surgeon.
Research has been done to establish a general consensus
on how to treat these types of fractures. The Canadian
Orthopaedic Study [9] has provided some insight into
how the outcomes after locking plate fixation relate to
those after conservative treatment. However, this study
has the limitation of a considerable loss to follow-up, pre-
dominantly in the non-operatively treated group, which
makes it impossible to conclude with certainty that plate
fixation is preferred over conservative treatment in active
adults. ORIF is most cost-effective for patients who are
sensitive to mild functional deficits and strongly value a
more rapid return to normal function [4]. Considering
these statements, a new randomised controlled trial with
sufficient power is needed to provide evidence for a defi-
nitive, generally acceptable guideline for the treatment of
dislocated midshaft clavicular fractures. The results of
this study will help to clarify the question whether plate
fixation is superior to non-operative treatment in adults,
thereby considering incidence of non-union, functional
outcome, pain scores, Quality of Life, cosmetic aspects
and complications.
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